I 
117TH CONGRESS 
1ST SESSION H. R. 5642 
To make any individual who is demonstrated to have antibodies to the 
virus that causes COVID–19 exempt from any Federal mandate for 
vaccination against COVID–19. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 20, 2021 
Mr. ISSA introduced the following bill; which was referred to the Committee 
on Energy and Commerce 
A BILL 
To make any individual who is demonstrated to have anti-
bodies to the virus that causes COVID–19 exempt from 
any Federal mandate for vaccination against COVID– 
19. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Follow Accepted 
Science Together Act of 2021’’. 
SEC. 2. FINDINGS. 
The Congress finds as follows: 
VerDate Sep 11 2014 
05:18 Oct 22, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5642.IH
H5642
kjohnson on DSK79L0C42PROD with BILLS
(1) The National Institutes of Health reported 
in March, 2021, that ‘‘people who have had evidence 
of a prior infection with SARS–CoV–2 . . . appear 
to be well protected against being reinfected with the 
virus . . .’’. The study stated, ‘‘the data from this 
study suggest that people who have had a positive 
result from a commercial antibody test appear to 
have substantial immunity to SARS–CoV–2 which 
means they are at a lower risk for future infection’’. 
(2) The National Institutes of Health reported 
in January 2021, that ‘‘after people recover from in-
fection with a virus, the immune system retains a 
memory of it. Immune cells and proteins that cir-
culate in the body can recognize and kill the patho-
gen if it’s encountered again, protecting against dis-
ease and reducing illness severity. All of these im-
mune system components have been found in people 
who recover from SARS–CoV–2, the virus that 
causes COVID–19. Researchers found durable im-
mune responses in the majority of people studied.’’. 
(3) A study at Emory University in July 2021, 
found that recovered COVID–19 patients retain 
broad and effective longer-term immunity to the dis-
ease. The study looked at 254 patients with mild to 
moderate symptoms over a period of eight months 
VerDate Sep 11 2014 
02:28 Oct 27, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5642.IH
H5642
kjohnson on DSK79L0C42PROD with BILLS
and found that their immune response to the virus 
remained durable and strong. 
(4) Patient and doctor relationships should al-
ways be paramount and forefront in each patient’s 
life. 
(5) Religious, mental health, physical health, 
immune health, and other exemptions from vaccina-
tion requirements give patients and doctors the flexi-
bility to adapt to the limitations or prerequisites of 
a patient’s health. 
SEC. 3. INAPPLICABILITY OF ANY COVID–19 VACCINE MAN-
DATE TO INDIVIDUALS WITH ANTIBODIES. 
Any individual who is demonstrated to have anti-
bodies to the virus that causes COVID–19 shall be exempt 
from any Federal mandate for vaccination against 
COVID–19. 
Æ 
VerDate Sep 11 2014 
05:18 Oct 22, 2021
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H5642.IH
H5642
kjohnson on DSK79L0C42PROD with BILLS